X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Biden Aims To Boost US Biomanufacturing Under Chinese Threat

Content Team by Content Team
16th September 2022
in Manufacturing, News
Biden Aims To Boost US Biomanufacturing Under Chinese Threat

The Biden Administration is previewing its next step in regaining American leadership in the pharmaceutical industry after focusing on the country’s supply chains for pharmaceuticals last winter. On September 12th, President Joe Biden signed an executive order to advance biotechnology and biomanufacturing in a number of sectors in the United States.

According to a White House statement by Vice President Joe Biden, in order for the American biotech industry to reach its full potential, the country must invest in the advancement of genetic engineering technology, use techniques like artificial intelligence to unlock the power of biomedical information, scale up production, and remove barriers to commercialization so that new products can enter the market more quickly.

The Biden Administration intends to increase federal funding for biotech and biomanufacturing R&D in order to advance those goals. Additionally, the administration wants to increase domestic biomanufacturing production. The President also stated that the Administration’s goal is to develop and evaluate bio-initiatives in order to speed up the translation of fundamental research achievements into practise.

The White House has not yet specified the project’s funding goals in detail. It said in a fact sheet that it will conduct a conference on the project on September 14th and make announcements about a wide range of new expenditures and capabilities that will enable the United States to capitalize on the full potential of biotech and biomanufacturing.

The bio industry’s expansion seems to be a response, at least in part, to rivalry from China, which has a thriving biotech industry of its own. Other countries, including and specifically China, are vigorously engaging in this sector, a White House representative told Reuters over the weekend.

Although the United States is home to some of the world’s top biotech inventors, they risk falling behind, a second official added during a conference call.

Additionally, the ruling comes at a bad time for the biotech sector, which until 2021 was breaking funding and IPO records. Despite this increase, venture capital investments in American biotech companies fell 46% during the first quarter of 2022 when compared to the same period in 2021, according to GlobalData. The dip was attributed by the analytics company to current economic and geopolitical uncertainty.

The new executive order covers a wide range of industries, from medicine to cutting-edge plastics and biofuels, to bring them back to Biden’s biotech programme. And this isn’t the first time Biden has taken action to revitalise the country’s biopharma industry.

The White House announced in June that it would create a public-private partnership to identify 50 to 100 important medications for an increased onshoring endeavour, after a February 2021 executive order requiring a multi-industry evaluation of key American supply chains. In order to increase domestic API production, the government set aside around $60 million at the time for technological development.

However, not all industry experts are certain that onshoring alone or the relocation of manufacturing to American soil can resolve the sector’s disjointed supply networks. Detailed manufacturing localization would speed up and improve the efficiency of production, but this agility would be bought at the cost of a substantial loss of productivity given the requirement to build and maintain infrastructure, services, and talent at local sites, consulting firm EY opined earlier this summer. EY’s message was very apparent in a report on strengthening the industry’s supply chains: in the end, some mix of localisation and other measures may be the most appropriate solution.

Previous Post

$300mn To Be Funded By Novartis In European Biotherapeutics

Next Post

WHO Advocates For More Research For Long COVID Patients

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post

WHO Advocates For More Research For Long COVID Patients

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In